Biotechnology company, AquaBounty Technologies, Inc. has received regulatory approval in Canada for the sale of its GM salmon which it says is an important step towards commercialisation.
AquaBounty Technologies has announced that the US Food and Drug Administration (FDA) had approved its new animal drug application for the production, sale and consumption of its AquaAdvantage Salmon.
Environmental groups are in dispute with the Canadian government over the manufacturing of genetically modified salmon in the country.
America’s AquaBounty Technologies has announced that the FDA’s Environmental Assessment of its AquAdvantage Salmon treatment is due for publication, a significant part of the FDA approval process for the product.
AquaBounty Technologies is now able to produce its AquAdvantage Salmon (AAS) on a commercial scale after being approved by Environment Canada.
In the midst of the ongoing debate in the US on the introduction of genetically modified transgenic salmon, Marine Harvest and WWF-Norway have said that if GM salmon is approved for human consumption then it must be labelled as such.
We are looking for a Systems Administrator to join our award winning B2B media company. Read more
We are currently seeking applications for a Fisheries Advisor within Marine Scotland Science based i... Read more
Marine Harvest Fish Feed (MHFF) is one of the newest divisions within Marine Harvest. Read more
An enthusiastic team player is required by Bibury Trout Farm to work in our fish shop area. Read more
BioMar is looking for a technically strong biologist/engineer with an interest in aquaculture. The r... Read more